REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/31/2025
Back to search
Official data from USPTO
DYNACURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
04/01/2025
Trademark type
Word
Nice classes
5, 42
Filing date
02/04/2019
Registration date
03/31/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2020
Last transaction
04/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
DICKSON, DANA
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DYNACURE
Representatives
Liane L. Churney
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of neuromuscular disorders and orphan diseases; Pharmaceutical preparations and substances for the treatment of neuromuscular disorders and orphan diseases; Biological preparations for medical use for the treatment of neuromuscular disorders and orphan diseases
Class 42
Scientific research; Biological and medical research services; Clinical research in the fields of neuromuscular disorders and orphan diseases; Consultancy and research and development in the field of biotechnology; Research and development services in the field of biotherapeutic products; Product development and research services for others in the field of biotechnology; Conducting clinical trials for others; Providing laboratory research services in the fields of neuromuscular disorders and orphan diseases; Medical laboratory services; Pharmaceutical research and development; Consultancy in the pharmaceutical fieldconsulting services in the field of pharmaceutical research and development of pharmaceutical products for the treatment of neuromuscular disorders and orphan diseases; Providing information on medical and scientific research in the field of neuromuscular disorders and orphan diseasesbiotechnologypharmaceuticalsclinical trials; Consultancy services in the field of biotechnology
Publications
History of USPTO decisions and trademark events.
36 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/14/2020
FIMP
FINAL DISPOSITION PROCESSED
08/14/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/30/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2020
PUBO
PUBLISHED FOR OPPOSITION
01/14/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/25/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/25/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/11/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/04/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/04/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/04/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/13/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/13/2019
RFNT
REFUSAL PROCESSED BY IB
06/01/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/16/2019
RFRR
REFUSAL PROCESSED BY MPU
05/16/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/24/2019
CNRT
NON-FINAL ACTION WRITTEN
04/23/2019
DOCK
ASSIGNED TO EXAMINER
04/16/2019
MAFR
APPLICATION FILING RECEIPT MAILED
04/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/11/2019
Continuous trademark protection
Get notified about every new filing that threatens DYNACURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.